Imaging AUC Compendium Reviewer Acknowledgement

NCCN content reviewers play a critical role in the development and maintenance of the NCCN Drugs and Biologics Compendium, Biomarkers Compendium, Radiation Therapy Compendium, and Imaging Appropriate Use Criteria. Reviewers are selected from NCCN Clinical Practice Guideline panels based on their clinical expertise and specialist knowledge. NCCN would like to recognize and thank the following volunteers who reviewed in 2024 for contributing their time and expertise:

Ampullary Adenocarcinoma

  • Jared A. Christensen, MD
    University of Michigan Rogel Cancer Center

B-Cell Lymphomas

  • Andrew D. Zelenetz, PhD, MD
    Memorial Sloan Kettering Cancer Center

Biliary Tract Cancers

  • Al B. Benson III, MD, FACP, FASCO
    Robert H. Lurie Comprehensive Cancer Center of Northwestern University

  • Michael I. D'Angelica, MD, FACS
    Memorial Sloan Kettering Cancer Center

Bladder Cancer

  • Thomas W. Flaig, MD
    University of Colorado Cancer Center

  • Philippe E. Spiess, MD, MS, FACS, FRCS
    Moffitt Cancer Center

Bone Cancer

  • J. Sybil Biermann, MD
    University of Michigan Rogel Cancer Center

  • Angela C. Hirbe, PhD, MD
    Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

Breast Cancer

  • William J. Gradishar, MD
    Robert H. Lurie Comprehensive Cancer Center of Northwestern University

  • Meena S. Moran, MD
    Yale Cancer Center/Smilow Cancer Hospital

Cancer-Associated Venous Thromboembolic Disease

  • Mona Ranade, MD
    UCLA Jonsson Comprehensive Cancer Center

Castleman Disease

  • Andrew D. Zelenetz, PhD, MD
    Memorial Sloan Kettering Cancer Center

Central Nervous System Cancers

  • Louis B. Nabors, MD
    O'Neal Comprehensive Cancer Center at UAB

Esophageal and Esophagogastric Junction Cancers

  • Jaffer A. Ajani, MD
    The University of Texas MD Anderson Cancer Center

  • Thomas A. D'Amico, MD
    Duke Cancer Institute

Gastric Cancer

  • Jaffer A. Ajani, MD
    The University of Texas MD Anderson Cancer Center

  • Thomas A. D'Amico, MD
    Duke Cancer Institute

Gastrointestinal Stromal Tumors

  • John M. Kane III, MD
    Roswell Park Comprehensive Cancer Center

  • Margaret von Mehren, MD
    Fox Chase Cancer Center

Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate

  • Tuya Pal, MD
    Vanderbilt-Ingram Cancer Center

Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric

  • Jennifer M. Weiss, MS, MD
    University of Wisconsin Carbone Cancer Center

Head and Neck Cancers

  • Sharon A. Spencer, MD
    O'Neal Comprehensive Cancer Center at UAB

Hematopoietic Cell Transplantation

  • Alison W. Loren, MSCE, MD
    Abramson Cancer Center at the University of Pennsylvania

Hepatocellular Carcinoma

  • Al B. Benson III, MD, FACP, FASCO
    Robert H. Lurie Comprehensive Cancer Center of Northwestern University

  • Michael I. D'Angelica, MD, FACS
    Memorial Sloan Kettering Cancer Center

Hodgkin Lymphoma

  • Richard T. Hoppe, MD
    Stanford Cancer Institute

Kaposi Sarcoma

  • Erin G. Reid, MD
    UC San Diego Moores Cancer Center

  • Gita Suneja, MD, MSHP
    Huntsman Cancer Institute at the University of Utah

Lung Cancer Screening

  • Ella A. Kazerooni, MS, MD
    University of Michigan Rogel Cancer Center

  • Douglas E. Wood, MD, FRCSEd, FACS
    Fred Hutchinson Cancer Center

Melanoma: Cutaneous

  • Susan M. Swetter, MD
    Stanford Cancer Institute

Melanoma: Uveal

  • Susan M. Swetter, MD
    Stanford Cancer Institute

Multiple Myeloma

  • Natalie S. Callander, MD
    University of Wisconsin Carbone Cancer Center

  • Shaji K. Kumar, MD
    Mayo Clinic Comprehensive Cancer Center

Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions

  • Aaron T. Gerds, MD, MS
    Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute

Neuroblastoma

  • Rochelle Bagatell, MD
    Abramson Cancer Center at the University of Pennsylvania

Pancreatic Adenocarcinoma

  • Jared A. Christensen, MD
    University of Michigan Rogel Cancer Center

Pediatric Acute Lymphoblastic Leukemia

  • Hiroto Inaba, PhD, MD
    St. Jude Children's Research Hospital/The University of Tennessee Health Science Center

Pediatric Aggressive Mature B-Cell Lymphomas

  • Matthew J. Barth, MD
    Roswell Park Comprehensive Cancer Center

  • Ana C. Xavier, MD
    O'Neal Comprehensive Cancer Center at UAB

Pediatric Central Nervous System Cancers

  • Anita Mahajan, MD
    Mayo Clinic Comprehensive Cancer Center

Penile Cancer

  • Thomas W. Flaig, MD
    University of Colorado Cancer Center

  • Philippe E. Spiess, MD, MS, FACS, FRCS
    Moffitt Cancer Center

Primary Cutaneous Lymphomas

  • Stephen Ansell, PhD, MD
    Mayo Clinic Comprehensive Cancer Center

Prostate Cancer Early Detection

  • Preston C. Sprenkle, MD
    Yale Cancer Center/Smilow Cancer Hospital

Small Cell Lung Cancer

  • Apar Kishor P. Ganti, MD
    Fred & Pamela Buffett Cancer Center

Soft Tissue Sarcoma

  • John M. Kane III, MD
    Roswell Park Comprehensive Cancer Center

  • Margaret von Mehren, MD
    Fox Chase Cancer Center

Systemic Light Chain Amyloidosis

  • Natalie S. Callander, MD
    University of Wisconsin Carbone Cancer Center

  • Shaji K. Kumar, MD
    Mayo Clinic Comprehensive Cancer Center

Systemic Mastocytosis

  • Aaron T. Gerds, MD, MS
    Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute

T-Cell Lymphomas

  • Stephen Ansell, PhD, MD
    Mayo Clinic Comprehensive Cancer Center

Testicular Cancer

  • Timothy D. Gilligan, MS, MD
    Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute

  • Daniel W. Lin, MD
    Fred Hutchinson Cancer Center

Thymomas and Thymic Carcinomas

  • Robert I. Haddad, MD
    Dana-Farber/Brigham and Women's Cancer Center | Mass General Cancer Center

  • Dominick M. Lamonica, MD
    Roswell Park Comprehensive Cancer Center

Thyroid Carcinoma

  • Robert I. Haddad, MD
    Dana-Farber/Brigham and Women's Cancer Center | Mass General Cancer Center

  • Dominick M. Lamonica, MD
    Roswell Park Comprehensive Cancer Center

Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma

  • Natalie S. Callander, MD
    University of Wisconsin Carbone Cancer Center

  • Shaji K. Kumar, MD
    Mayo Clinic Comprehensive Cancer Center

Wilms Tumor (Nephroblastoma)

  • Frank M. Balis, MD
    Abramson Cancer Center at the University of Pennsylvania

  • Daniel M. Green, MD
    St. Jude Children's Research Hospital/The University of Tennessee Health Science Center